Philip P. Breitfeld is Director of CHAMPIONS ONCOLOGY, INC.. Currently has a direct ownership of 5,717 shares of CSBR, which is worth approximately $45,164. The most recent transaction as insider was on Mar 25, 2025, when has been sold 4,150 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.72K
60.94% 3M change
60.94% 12M change
Total Value Held $45,164

Philip P. Breitfeld Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2025
SELL
Other acquisition or disposition
-
4,150 Reduced 42.06%
5,717 Common Stock
Oct 12 2022
SELL
Payment of exercise price or tax liability
$26,751 $7.51 p/Share
3,562 Reduced 19.57%
14,638 Common Stock
Oct 12 2022
BUY
Exercise of conversion of derivative security
$26,749 $3.21 p/Share
8,333 Added 31.41%
18,200 Common Stock
Mar 23 2021
SELL
Payment of exercise price or tax liability
$15,209 $11.35 p/Share
1,340 Reduced 32.16%
2,827 Common Stock
Mar 23 2021
BUY
Exercise of conversion of derivative security
$15,210 $3.65 p/Share
4,167 Added 50.0%
4,167 Common Stock
Dec 16 2020
SELL
Open market or private sale
$356,878 $11.35 p/Share
31,443 Reduced 100.0%
0 Common Stock
PPB

Philip P. Breitfeld

Director
Hackensack, NJ

Track Institutional and Insider Activities on CSBR

Follow CHAMPIONS ONCOLOGY, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSBR shares.

Notify only if

Insider Trading

Get notified when an Champions Oncology, Inc. insider buys or sells CSBR shares.

Notify only if

News

Receive news related to CHAMPIONS ONCOLOGY, INC.

Track Activities on CSBR